Description
“The situation has become quite complex – advanced microscopy is now a vast forest filled with a multitude of individual trees.”
Modern fluorescent techniques, from confocal microscopy through the novel super-resolution techniques of today, are the focus of this report. Treating them collectively as advanced microscopy helps to separate this more exciting segment from the overall microscopy market. These tools help researchers to approach or break through the diffraction limit, which limits microscope resolution of traditional microscopes to a few hundred nanometers. As both life science and materials science researchers probe ever further into the realm of the nanoscale, greater resolution and capabilities from fluorescence microscopy are enabling new areas of investigation.
The situation has become quite complex – advanced microscopy is now a vast forest filled with a multitude of individual trees representing specific techniques that have now been successfully commercialized. Each technique has specific advantages and drawbacks that appeal to different researchers, depending on their specific applications and needs. Vendors need guidance on the preferences, needs, and opinions of these researchers in order to present a product portfolio to market that will be successful.
Estimates for market demand and growth are developed across various relevant segments for these technologies, as well as information on vendor share. The results of a survey of 328 users of these advanced microscopy technologies are explored, providing insight on current usage, future budgeting, and opinions about different techniques and vendors.
Companies mentioned in this report:
- Andor (Oxford Instruments)
- Becton Dickinson
- Bio-Rad
- Bruker
- Carl Zeiss
- GE Healthcare
- Huron Digital Pathology
- JenLab
- Keyence
- Lasertec
- LaVision BioTec
- Leica (Danaher)
- Olympus
- PicoQuant
- Nikon
- Scientifica
- Spectra-Physics (Newport)
- Thermo Fisher Scientific
- Visitech
- Yokogawa
Please download the complimentary Report Brochure (upper left corner of your screen) to review the detailed objectives, table of contents, and sample data.
For additional questions, please contact:
Devin Holland
703.778.3080 x19
reports@gene2drug.com
